APA (7th ed.) Citation

A, E., L, S., SI, V., LA, H., CA, L., V, F., . . . C, L. (2023). Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(5), 866. https://doi.org/10.1158/1078-0432.CCR-22-2060

Chicago Style (17th ed.) Citation

A, Elía, et al. "Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29, no. 5 (2023): 866. https://doi.org/10.1158/1078-0432.CCR-22-2060.

MLA (9th ed.) Citation

A, Elía, et al. "Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 5, 2023, p. 866, https://doi.org/10.1158/1078-0432.CCR-22-2060.